Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes

Ítems similars

• Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across Studies
  per: Heise, Tim, et al.
  Publicat: (2017)
• A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
  per: Haahr, Hanne, et al.
  Publicat: (2016)
• Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
  per: Buscemi, Silvio, et al.
  Publicat: (2019)
• Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
  per: Yamabe, Mizuho
  Publicat: (2019)
• In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
  per: Schiavon, Michele, et al.
  Publicat: (2020)